Skip to main content
Clinical Trials/CTRI/2023/03/050945
CTRI/2023/03/050945
Not yet recruiting
未知

A clinical study to evaluate the efficacy of Virechana karma and Punarnavadi Niruha Basti along with Shamana chikitsa in stage i and stage ii Chronic kidney disease -A continuous study

J S AYURVED MAHAVIDYALAYA0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
J S AYURVED MAHAVIDYALAYA
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
J S AYURVED MAHAVIDYALAYA

Eligibility Criteria

Inclusion Criteria

  • 1\.PATIENTS HAVING SERUM CREATININE LEVEL BETWEEN 1\.4 MG/DL TO 3\.0 MG/DL
  • 2\.PATIENTS INDICATED FOR VIRECHANA KARMA AND BASTI KARMA

Exclusion Criteria

  • 1\.FEMALE PATIENTS HAVING PREGNANCY, BREAST FEEDING OR POST\-DELIVERY PERIOD 2\.PATIENTS OF END STAGE KIDNEY DISEASE
  • 3\.PATIENTS WHO ARE ON DIALYSIS TREATMENT
  • 4\.PATIENTS WHO HAVING PREVIOUS HISTORY OF RENAL TRANSPLANTATION 5\.PATIENTS OF HEPATO\-RENAL INSUFFICIENCY OR RENAL INSUFFICIENCY DUE TO HAEMODYNEMIC CIRCULATORY DISORDERS AND CCF
  • 6\.PATIENTS WITH SOME SERIOUS ILLNESS LIKE CARDIO\-VASCULAR DISEASES, PSYCHOLOGICAL DISORDERS, SERIOUS ACUTE ORGANIC DISEASES, SERIOUS CHRONIC CO\-MORBIDITIES, LIVER DISORDERS OR METABOLIC DISORDERS ETC
  • 7\.PATIENTS WITH ANY BLEEDING DISORDERS
  • 8\.PATIENTS CONTRAINDICATED FOR VIRECHANA KARMA AND BASTI KARMA

Outcomes

Primary Outcomes

Not specified

Similar Trials